Multi-CAR-T Cells Targeting B Cell Lymphomas

NCT04429438 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

11

Enrollment

OTHER

Sponsor class

Conditions

B Cell Lymphoma (BCL)

Interventions

BIOLOGICAL: 4SCAR19 and 4SCAR20/22/70/PSMA/13/79b/GD2

Sponsor

Shenzhen Geno-Immune Medical Institute

Collaborators

[object Object]
[object Object]